BOSTON / ACCESSWIRE / February 22, 2024 / OmniGuide™ Holdings (OGH) and UROTECH® (part of the Medi-Globe Group, a subsidiary of DCC plc) have announced a new partnership to strengthen UROTECH's technology portfolio for urologists. As part of the collaboration, the partnership will work with urologists to build a global network for RevoLix™ HTL (Hybrid Thulium Laser Therapy) specifically for kidney stones and benign prostatic hyperplasia (BPH)..

波士顿/ACCESSWIRE/2024年2月22日/OmniGuide™Holdings（OGH）和UROTECH®（Medi-Globe Group的一部分，DCC plc的子公司）宣布建立新的合作伙伴关系，以加强UROTECH对泌尿科医生的技术组合。作为合作的一部分，该合作伙伴关系将与泌尿科医生合作，建立专门针对肾结石和良性前列腺增生（BPH）的RevoLix™HTL（混合铥激光治疗）全球网络。。

UROTECH is one of the leading medical technology manufacturers in the field of minimally invasive urology. The treatment of kidney stones is at the heart of UROTECH's work, which is committed to the highest quality standards for its products and clinical experience. As a determined and reliable medical partner, UROTECH supports the daily work of urologists..

UROTECH是微创泌尿外科领域领先的医疗技术制造商之一。肾结石的治疗是UROTECH工作的核心，UROTECH致力于其产品和临床经验的最高质量标准。作为坚定可靠的医疗合作伙伴，UROTECH支持泌尿科医生的日常工作。。

Surgeons and nurses recognize OmniGuide's ability to deliver advanced solutions for some of the most important surgical therapies in urology. OmniGuide's innovative focus on robotics, precision light therapies and biosensing software enables the company to cover a wide range of urological procedures and reduce complications every day..

外科医生和护士认识到OmniGuide能够为泌尿外科中一些最重要的手术疗法提供先进的解决方案。OmniGuide对机器人技术、精密光疗法和生物传感软件的创新关注使该公司能够覆盖广泛的泌尿外科手术，并每天减少并发症。。

The aim of the global collaboration is to support future surgical trends by providing access to data and insights for urological decisions. The partnership will accelerate these efforts as two global companies work toward a common goal and bring their surgical expertise.

全球合作的目的是通过提供泌尿外科决策的数据和见解来支持未来的手术趋势。随着两家全球性公司朝着一个共同的目标努力，并带来他们的外科专业知识，该合作伙伴关系将加速这些努力。

OmniGuide Urology will support projects with UROTECH including:

OmniGuide泌尿科将支持UROTECH的项目，包括：

Scaling global capacity for Kidney Stones and BPH Treatments through the newly launched RevoLix™ HTL Hybrid Thulium Laser.

通过新推出的RevoLix™HTL混合铥激光器扩大肾结石和BPH治疗的全球容量。

User-centered strategies for existing urologists, delivering solutions to better support a great clinical experience.

为现有泌尿科医生提供以用户为中心的策略，提供解决方案以更好地支持出色的临床体验。

Increase advocacy through partnering and establishing a forum in urology.

通过合作和建立泌尿外科论坛来加强宣传。

Developing a biosensing software platform in partnership with the OmniGuide™ Institute for Biomedical Innovation.

与OmniGuide™生物医学创新研究所合作开发生物传感软件平台。

'UROTECH is known for its customer focus and the user-centric development and distribution of innovative solutions for urologists worldwide. The partnership with OmniGuide fits into this mindset, to make the revolutionary all-in-one RevoLix HTL laser technology and its great benefits available to our customers,' said Dr.

“UROTECH以其以客户为中心，以用户为中心为全球泌尿科医生开发和分发创新解决方案而闻名。与OmniGuide的合作符合这种思维模式，使革命性的一体式RevoLix HTL激光技术及其巨大的利益可供我们的客户使用。

Markus Schönberger, Director Business Development and Head of the Strategic Business Unit Urology of the Medi-Globe Group..

Markus Schönberger，Medi Globe Group业务发展总监兼战略业务部门泌尿科主管。。

'Biosensing Innovation is increasing both the need to collaborate and share data,' said M.T. Henderson CEO OmniGuide Holdings™ (OGH). 'Solutions that connect outcomes with recent technology are at the core of our collective purpose. We are proud to partner with UROTECH to expand our shared vision of helping to improve patient lives, fueled by innovation-forward therapies.'.

亨德森首席执行官OmniGuide Holdings™（OGH）说，生物传感创新正在增加合作和共享数据的需求将成果与最新技术联系起来的解决方案是我们共同目标的核心。我们很自豪能与UROTECH合作，扩大我们的共同愿景，在创新前沿疗法的推动下，帮助改善患者生活。”。

About OmniGuide Holdings

关于OmniGuide Holdings

Headquartered in Billerica, Massachusetts, USA, OmniGuide is a leader in the design, development, and marketing of patient safety-focused advanced energy surgical tools to benefit clinicians and their patients. OmniGuide is a privately held company, majority owned by an investment fund managed by OrbiMed Advisors LLC..

OmniGuide总部位于美国马萨诸塞州的Billerica，是以患者安全为中心的先进能量手术工具的设计、开发和营销领域的领导者，旨在造福临床医生及其患者。OmniGuide是一家私营公司，由OrbiMed Advisors LLC管理的投资基金持有多数股权。。

About UROTECH

关于UROTECH

UROTECH is a Medi-Globe Group company, which is part of DCC Healthcare, one of three divisions of DCC plc, an Ireland-based FTSE 100 listed company. The head office of UROTECH is in Achenmühle in Chiemgau, Bavaria, south of Munich, Germany.

UROTECH是一家Medi-Globe集团公司，是DCC Healthcare的一部分，DCC Healthcare是总部位于爱尔兰的富时100指数上市公司DCC plc的三个部门之一。UROTECH总部位于德国慕尼黑南部巴伐利亚州基姆高的Achenmühle。

The Medi-Globe Group is an innovative, fast-growing, and internationally oriented group of medical technology companies in the fields of urology, gastroenterology and pneumology.

Medi-Globe集团是一家创新、快速发展、面向国际的泌尿科、胃肠病学和肺病学领域医疗技术公司集团。

UROTECH serves its customers including university hospitals, specialist clinics, and special medical facilities in 50 countries worldwide.

UROTECH为其客户提供服务，包括全球50个国家的大学医院、专科诊所和特殊医疗设施。

Media Contact

媒体联系人

Iris Schäfer Medi-Globe Group: press@medi-globe.de

Iris Schäfer Medi Globe集团：press@medi-globe.de

Tullio Cappelletto OmniGuide Holdings: Tcappelletto@omni-guide.com

Tullio Cappelletto OmniGuide Holdings：Tcappelletto@omni-guide.com

Contact Information

联系方式

Iris Schäfer

Iris Schäfer

press@medi-globe.de

press@medi-globe.de

Tullio Cappelletto

Tullio Cappelletto

tcappelletto@omni-guide.com

tcappelletto@omni-guide.com

SOURCE: OmniGuide Holdings (OGH)

资料来源：OmniGuide Holdings（OGH）

View the original press release on newswire.com.

在newswire.com上查看原始新闻稿。